Looking beyond VEGF to target BRB dysfunction in DME: Novel approaches to prevent vision loss

touchEXPERT FOCUS for touchOPHTHALMOLOGY Listen to a series of interviews with Dr. Diana Do as she shares her expert insights into the epidemiology and quality‑of‑life burden of diabetic macular edema (DME) in the USA, outlines real‑world limitations of current anti‑VEGF–based management, and examines emerging therapies that specifically target blood–retinal barrier (BRB) dysfunction and aim to provide more durable vision protection. The expert: Dr. Diana Do, Stanford University School of Medicine, Palo Alto, CA, USA This touchPODCAST is for HCPs in the USA only. This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC. This activity is jointly provided by USF Health and touchIME. For further information visit our website: www.touchOPHTHALMOLOGY.com